GlaxoSmithKline's (GSK) Press Release Issued: Thursday 20th November 2008, London UK GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix TM, was today confirmed by the Netherlands Vaccine Institute (NVI) as the cervical cancer vaccine for the Dutch National Immunisation … [Read more...] about Cervarix, GSK’s Cervical Cancer Vaccine, Wins Tender For Dutch National Immunisation Programme
Cervarix
GlaxoSmithKline responds to FDA on Cervarix
Glaxo plans to submit final Cervarix study data for approval Issued – Monday 30 June 2008, London, UK & Philadelphia, US GlaxoSmithKline today provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of … [Read more...] about GlaxoSmithKline responds to FDA on Cervarix
Glaxo’s Cervarix Not Feeling the FDA Love
HPV Vaccine In-Waiting Glaxo, still struggling to overcome the Avandia diabetes pill controversy and subsequent lost revenue, has been dealt another blow by the FDA. The agency has issued a “complete response letter” to Glaxo for its Cervarix vaccine. It is unclear whether the … [Read more...] about Glaxo’s Cervarix Not Feeling the FDA Love
Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market